Roy Sperling wird zum 1. Oktober 2025 als zweiter Geschäftsführer der bilacon ernannt

Die bilacon GmbH freut sich, bekanntzugeben, dass Herr Roy Sperling ab dem 1. Oktober 2025 gemeinsam mit Herrn Frank Barsch die Geschäftsführung des Unternehmens übernehmen wird. Roy Sperling ist seit vielen Jahren fest mit der bilacon verbunden. Bereits 2010 begann er als Werkstudent in Berlin und übernahm im Laufe der Jahre zahlreiche verantwortungsvolle Positionen – […]

continue reading

When QM works, it becomes a supporting structure. TentaConsult puts regulatory thinking into practice

Quality management should not be administrative, but should relieve the burden – create clarity, provide security and function in day-to-day operations. This is exactly where TentaConsult comes in: The consulting team with offices in Münster and Martinsried supports players from the medical technology, pharmaceutical, cosmetics and food supplements sectors in not only fulfilling complex regulatory […]

continue reading

Wenn QM funktioniert, wird es zur tragenden Struktur. TentaConsult bringt regulatorisches Denken in die Praxis

Qualitätsmanagement soll nicht verwalten, sondern entlasten – Klarheit schaffen, Sicherheit geben und im Betriebsalltag funktionieren. Genau dort setzt TentaConsult an: Das Beratungsteam mit Standorten in Münster und Martinsried unterstützt Akteure aus Medizintechnik, Pharma, Kosmetik und Nahrungsergänzungsmitteln dabei, komplexe regulatorische Anforderungen nicht nur zu erfüllen, sondern sie in lebendige und tragfähige Strukturen zu übersetzen. TentaConsult steht […]

continue reading

BDC Laboratories Partners with Dilawri Cardiovascular Institute to Improve Heart Device Performance and Patient Outcomes

BDC Laboratories, a Tentamus Company and recognized leader in cardiovascular device testing solutions, has announced a strategic partnership with the newly established Dilawri Cardiovascular Institute (DCI). This collaboration is set to accelerate the development, validation, and clinical relevance of next-generation cardiovascular medical devices. DCI comprises 16 core centers uniting research with every aspect of cardiac […]

continue reading

Microbiological Stability in Beer: tailored Testing for Long-Lasting Quality

Microbiological stability is a key parameter for ensuring the long-term quality and safety of beer. Preventing contamination by unwanted yeasts or bacteria helps preserve its organoleptic properties and ensures a shelf-life aligned with market expectations. The Centro Analisi CAIM laboratory, drawing on extensive expertise in the beverage sector, offers a dedicated service for assessing the […]

continue reading

As COFEPRIS Advances Nitrosamine Strategy, Lambda Científica Shares Critical Testing Insights

As COFEPRIS advances to Stage 2 (confirmation) and Stage 3 (mitigation) of its national nitrosamine risk management strategy, pharmaceutical companies in Mexico face increasing pressure to validate their analytical methods and implement robust mitigation plans. With these changes creating immediate regulatory urgency, Lambda Científica, a Tentamus Company, is stepping up to guide the industry with […]

continue reading

The Tentamus Group welcomes James Murphy as Vice President of Sales & Marketing for Tentamus North America

James Murphy is a seasoned commercial executive with over 18 years of experience driving strategic growth and leading high-performing sales and marketing teams in the life sciences and analytical testing sectors. Prior to joining Tentamus North America, James held a senior commercial leadership role within the Testing, Inspection, and Certification (TIC) industry, where he played […]

continue reading

BluTest Laboratories Expands UKAS Accreditation with EN 16777 for Advanced Virucidal Surface Testing

BluTest Laboratories – A Tentamus Company is pleased to announce a significant expansion to its UKAS accreditation scope with the addition of EN 16777, a critical virucidal Phase 2 Step 2 surface efficacy test designed for non-porous surfaces in medical settings. This marks the second scope extension for BluTest Laboratories in 2025, reflecting our continued […]

continue reading